维普中文期刊产品整合服务
89篇 您的检索式:作者名="Bonet S"
    题名 作者 年代 出处 被引量
1Tenofovir vs lamivudine plus adefovir in chronic hepatitis B:TENOSIMP-B study显示文摘AIM To demonstrate the non-inferiority(15% non-inferiority limit) of monotherapy with tenofovir disoproxil fumarate(TDF) vs the combination of lamivudine(LAM) plus adefovir dipivoxil(ADV) in the maintenance of virologic response in patients with chronic hepatitis B(CHB) and prior failure with LAM.METHODS This study was a Phase IV prospective, randomized, open, controlled study with 2 parallel groups(TDF and LAM+ADV) of adult patients with hepatitis B e antigen(HBe Ag)-negative CHB, prior failure with LAM, on treatment with LAM+ADV for at least 6 mo, without prior resistance to ADV and with an undetectable viral load at the start of the study, in 14 Spanish hospitals. The follow-up time for each patient was 48 wk after randomization, with quarterly visits in which the viral load, biochemical and serological parameters, adverse effects, adherence to treatment and consumption of hospital resources were analysed.RESULTS Forty-six patients were evaluated [median age: 55.4 years(30.2-75.2); 84.8% male], including 22 patients with TDF and 24 with LAM+ADV. During study development, hepatitis B virus DNA(HBV-DNA) remained undetectable, all patients remained HBe Ag negative, and hepatitis B surface antigen(HBs Ag) positive. Alanine aminotransferase(ALT) values at the end of the study were similar in the 2 groups(25.1± 7.65, TDF vs 24.22 ± 8.38, LAM+ADV, P = 0.646). No significant changes were observed in creatinine or serum phosphorus values in either group. No significant differences between the 2 groups were noted in the identification of adverse effects(AEs)(53.8%, TDF vs 37.5%, LAM+ADV, P = 0.170), and none of the AEs which occurred were serious. Treatment adherence was 95.5% and 83.3% in the TDF and the LAM+ADV groups, respectively(P = 0.488). The costs associated with hospital resource consumption were significantly lower with the TDF treatment than the LAM+ADV treatment(€4943 ± 1059 vs €5811 ± 1538, respectively, P < 0.001).CONCLUSION TDF monotherapy proved to be safe and not inferior to the LAM+ADV combination therapy in maintaining virologic response in patients with CHB and previous LAM failure. In addition, the use of TDF generated a significant savings in hospital costs.Manuel Rodríguez Juan Manuel Pascasio Enrique Fraga Javier Fuentes Martín Prieto Gloria Sánchez-Antolín Jose Luis Calleja Esther Molina María Luisa García-Buey María Angeles Blanco Javier Salmerón María Lucía Bonet Jose Antonio Pons Jose Manuel González Miguel Angel Casado Francisco Jorquera 2017World Journal of Gastroenterology2017,23,41:16
2The endothelia cell protein C receptor:Its role in thrombosis显示文摘Navarro S Bonet E Estelles A 2011Thromb Res2011,128,5:1
3High pressure die casting simulation using a lagrangian particle method显示文摘Kulasegaram S Bonet J Lewis J 2003Communication in Numerical Methods in Engineering2003,19,9:1
4Correction and stabilization of smooth particle hydrodynamics methods with applications in metal forming simulations显示文摘BONET J KULASEGARAM S 2000International Journal of Numerical Methods in Engineering2000,47,:1
5Variational formulation based Contaet algorithm for rigid boundaries in twodimensional SPH applications显示文摘Kulasegaram S Bonet J Lewis RW 2004Computational Mechanics2004,33,:1
6Beta-adrenergic blocking agents in heartfailure:benefits of vasodilating and non-vasodilating agents according to patients′characteristics:a meta-analysis of clinical trails显示文摘Bonet S Agusti A Arnau JM 2000Arch Intern Med2000,160,:1
7Functional analysisof two haplotypes of the human endothelial protein C re-ceptor gene显示文摘Medina P Navarro S Bonet E 2014Arterioscler Thromb Vase Biol2014,34,3:1
8The formation of wrinkles in single-layer graphene sheets under nanoindentation显示文摘A J Gil S Adhikari F Scarpa J Bonet 2010Journal of Physics: Condensed Matter2010,,14:1
9Correction and stabilization methods for smooth particle hydrodynamics method with applications to metal forming simulations 显示文摘Bonet J Kulasegaram S 2000Compu Methods Appl Mech Engrg2000,47,:1
10A simplified approach to enhance the performance of smooth particle hydrodynamics methods 显示文摘BONET J KULASEGARAM S 2002Applied Mathematics and Computation2002,326,2:1
11Synthesis of nanodisperse Au, Pt, Pd, Ru and Ir nanoparticles in ethylene glycol 显示文摘Bonet F Delmas V Grugeon S 1999NanoStructured Materials1999,11,:1
12Multiresolution sampling procedure for analysis and synthesis of texture images显示文摘JEREMY S DE BONET 1997Computer Graphics1997,31,:1
13显示文摘Bonet F Delmas V Grugeon S 1999NanoStructured Materials1999,11,8:1
14Variational and Momentum Preser- vation Aspects of Smooth Particle Hydrodynamic Formu-lations显示文摘Bonet J Lok T S L 1999Computer Methods in Applied Mechanics and Engineering1999,180,1:1
15Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome(PNAS)显示文摘OHANNA M GIULIANO S BONET C 2011Genes Dev2011,25,12:1
16Synthesis of monodisperse Au,Pt,Pd,Ru and Ir nanoaprticles in ethylene glycol显示文摘BONET F DELMAS V GRUGEON S 1999NanoStructured Materials1999,11,8:1
17Synthesis of monodisperse Au, Pt, Pd, Ru and Ir nanoparticles in ethylene glycol 显示文摘Bonet F Delmas V Grugeon S 1999Nanostructured Materials1999,11,:1
18Multiresolution sampling procedure for analysis and synthesis of texture images显示文摘J S de Bonet 1997In Proc ACM Conf Comp Graphics (SIGGRAPH)1997,31,:1
19ACE inhibitors improve nephrin expression in Zueker rats with glomeruloselerosis显示文摘Blaneo S Bonet J L 6 pez D 2005Kidney Int2005,,:1
20Prevention of peritoneal adhesion by administration of sodium carboxymethlcellulose and oral vitamin E显示文摘Hemadeh O Chilukuri S bonet V 1993Surgery1993,114,5:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费